Trial intelligence / Profile preview

Lavender Essential Oil for Delirium in Elderly ICU Patients

NCT06100029Recruiting

Sponsor
Chongqing Traditional Chinese Medicine Hospital
Start
Nov 2023
Primary completion
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of Silexan in delirium (2 arms), sponsored by Chongqing Traditional Chinese Medicine Hospital. Primary endpoint: Prevalence of delirium. Started Nov 2023; status: recruiting.

02

Drugs

Silexan
03

Conditions

delirium

Beyond the preview

Go deeper on NCT06100029.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06100029.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call